or Try an Advanced Search...

    Technical Analysis for EXAI - Exscientia Limited

    Grade Last Price % Change Price Change
    D 4.84 3.20% 0.15
    EXAI closed up 3.2 percent on Tuesday, November 19, 2024, on 2.09 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical EXAI trend table...
    Date Alert Name Type % Chg
    Bullish Engulfing Bullish 0.00%
    Oversold Stochastic Weakness 0.00%
    Hammer Candlestick Bullish 3.20%
    Lizard Bullish Bullish Day Trade Setup 3.20%
    Calm After Storm Range Contraction 3.20%
    Stochastic Reached Oversold Weakness 3.20%
    Lower Bollinger Band Touch Weakness 3.20%
    Oversold Stochastic Weakness 3.20%
    Fell Below 20 DMA Bearish 3.20%
    Fell Below 200 DMA Bearish 3.20%
    Older End-of-Day Signals for EXAI ...

       Recent Intraday Alerts

    Alert Time
    Up 3% 2 days ago
    Lizard Bullish Entry 2 days ago
    Hammer Candlestick Entry 2 days ago
    Rose Above Previous Day's High 2 days ago
    Up 2% 2 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    EXAI Chart by TradingView
    Basic chart:

    Profile

    Exscientia is an AI-driven pharmatech company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Our pipeline demonstrates our ability to rapidly translate scientific concepts into precision-designed therapeutic candidates, with more than 25 projects advancing, including the first three AI-designed drug candidates to enter Phase 1 clinical trials.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Life Sciences Artificial Intelligence Health Sciences Clinical Trial Precision Medicine Clinical Pharmacology Systems Biology Evidence Based Medicine

    Is EXAI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 20 Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery
    Oct 17 Exscientia advances two additional discovery programs with Sanofi
    Oct 16 Exscientia to receive $15M in milestones for Sanofi collaboration
    Oct 16 Exscientia Achieves Milestones for Two Programmes in Sanofi Collaboration
    Oct 12 Recursion’s All-Stock Acquisition of Exscientia plc (EXAI): NVIDIA-Backed Merger to Revolutionize AI-Driven Drug Discovery
    Oct 11 Exscientia Set for Strategic Acquisition by Recursion
    Oct 10 Recursion, Exscientia seek support for merger ahead of special meeting
    Oct 9 Exscientia to Present New Preclinical Data for AI-designed LSD1 and MALT1 Inhibitors at ENA 2024
    Oct 4 Harrow (HROW) Surges 8.4%: Is This an Indication of Further Gains?
    Oct 2 Exscientia outline robot and AI use in drug discovery workflow
    See more EXAI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.91
    52 Week Low 3.8
    Average Volume 720,981
    200-Day Moving Average 5.29
    50-Day Moving Average 5.04
    20-Day Moving Average 5.15
    10-Day Moving Average 5.30
    Average True Range 0.36
    RSI (14) 44.13
    ADX 21.0
    +DI 25.16
    -DI 25.97
    Chandelier Exit (Long, 3 ATRs) 5.40
    Chandelier Exit (Short, 3 ATRs) 5.54
    Upper Bollinger Bands 5.84
    Lower Bollinger Band 4.45
    Percent B (%b) 0.28
    BandWidth 27.01
    MACD Line 0.00
    MACD Signal Line 0.07
    MACD Histogram -0.0676
    Fundamentals Value
    Market Cap 604.71 Million
    Num Shares 125 Million
    EPS -1.48
    Price-to-Earnings (P/E) Ratio -3.27
    Price-to-Sales 34.58
    Price-to-Book 1.59
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.39
    Resistance 3 (R3) 5.33 5.09 5.30
    Resistance 2 (R2) 5.09 4.95 5.12 5.27
    Resistance 1 (R1) 4.97 4.86 5.03 5.02 5.24
    Pivot Point 4.73 4.73 4.76 4.75 4.73
    Support 1 (S1) 4.60 4.59 4.66 4.66 4.44
    Support 2 (S2) 4.36 4.50 4.39 4.41
    Support 3 (S3) 4.24 4.36 4.38
    Support 4 (S4) 4.29